Medical Condition News

RSS

New study sheds light on stroke risk factors among racial and ethnic groups

A new study led by a University of Cincinnati researcher sheds light on risk factors for certain kinds of strokes among different racial and ethnic groups.

2 Sep 2021

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

A simple blood test could determine which drug and dosage is more likely to be effective against rheumatoid arthritis, potentially saving sufferers serious side effects and Australian taxpayers millions of dollars.

2 Sep 2021

New digital solution for people living with severe mental illnesses

The pandemic has made it more difficult for the 430,000+ Australians living with severe mental illnesses who are highly vulnerable to acute illness relapses when their habitual routines and standard health care arrangements are disrupted.

2 Sep 2021

Research investigates how drug-eluting stent affects arterial tissue permeability and blood flow

For patients with symptomatic coronary artery disease, the best course of action often involves implanting a drug-eluting stent into the artery where a plaque buildup is blocking blood flow to the heart.

2 Sep 2021

Trial tests effectiveness of two prospective stroke therapies over standard of care

Another goal of the study is to screen all participants for a mutation known to prevent clopidogrel, a prodrug, from being fully metabolized into its active form.

2 Sep 2021

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

A new study by researchers at Winship Cancer Institute of Emory University finds that cancer-associated mutations originate in blood progenitor cells, leading to distinct changes in both cancer and non-cancer immune cells in Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma and its precursor IgM monoclonal gammopathy of undetermined significance (MGUS).

2 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

Review: Remission should be the primary treatment goal of GPs for people with type 2 diabetes

Achieving 'remission' for people with type 2 diabetes through dietary approaches and weight loss should be the primary treatment goal of GPs and healthcare practitioners, concludes a large-scale review of clinical evidence led by researchers at UCL and Aston University.

2 Sep 2021

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

A new cohort study comparing immune responses among vaccinated elderly persons and healthcare workers has been conducted.

2 Sep 2021

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

Researchers at Children's Hospital of Philadelphia successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.

1 Sep 2021

'Forever chemicals' may increase the risk of type 2 diabetes in Latino girls, study finds

A new USC study finds that a class of environmental pollutants known as "forever chemicals" may increase the risk of type 2 diabetes in Latino girls.

1 Sep 2021

People with MS and depression have an increased risk of death, study shows

Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely to die over the next decade than people with just one or neither condition.

1 Sep 2021

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

A study by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

1 Sep 2021

Study could pave way for an effective approach to amblyopia treatment

Amblyopia is the most common cause of vision loss in children, according to the U.S. National Eye Institute.

1 Sep 2021

Cultured cartilage cells from the nasal septum could help relieve osteoarthritis in the knee

Cartilage cells from the nasal septum can not only help repair cartilage injuries in the knee – according to researchers from the University of Basel and the University Hospital of Basel, they can also withstand the chronic inflammatory tissue environment in osteoarthritis and even counteract the inflammation.

1 Sep 2021

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

Researchers from Cleveland Clinic and OhioHealth have published results from a first-in-human trial evaluating feasibility of Temporally Feathered Radiation Therapy (TFRT), which is designed to reduce the toxicity of radiation treatment.

1 Sep 2021

Cellular protein may be a potential new target for treating osteoporosis

A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Sep 2021

First pharmacological treatment option for patients with a severe form of epilepsy

Epilepsy comes in a variety of forms. Those affected by a genetically de- termined variety have severe epileptic seizures as early as the first year of life.

1 Sep 2021

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

1 Sep 2021

Family of proteins could be effective in reducing damage from ischemic stroke

Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston.

1 Sep 2021

Medical Condition News

New study sheds light on stroke risk factors among racial and ethnic groups

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

New digital solution for people living with severe mental illnesses

Research investigates how drug-eluting stent affects arterial tissue permeability and blood flow

Trial tests effectiveness of two prospective stroke therapies over standard of care

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Regional differences in prevalence of SARS-CoV-2 antibodies in children

Review: Remission should be the primary treatment goal of GPs for people with type 2 diabetes

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

'Forever chemicals' may increase the risk of type 2 diabetes in Latino girls, study finds

People with MS and depression have an increased risk of death, study shows

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

Study could pave way for an effective approach to amblyopia treatment

Cultured cartilage cells from the nasal septum could help relieve osteoarthritis in the knee

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

Cellular protein may be a potential new target for treating osteoporosis

First pharmacological treatment option for patients with a severe form of epilepsy

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

Family of proteins could be effective in reducing damage from ischemic stroke

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News